Literature DB >> 20045932

Proline-rich domain plays a crucial role in extracellular stimuli-responsive translocation of a Cdc42 guanine nucleotide exchange factor, FGD1.

Toshiyuki Oshima1, Tomofumi Fujino, Ken Ando, Makio Hayakawa.   

Abstract

We previously demonstrated that FGD1, the Cdc42 guanine nucleotide exchange factor (GEF) responsible for faciogenital dysplasia, and its homologue FGD3 are targeted by the ubiquitin ligase SCF(FWD1) upon phosphorylation of two serine residues in their DSGIDS motif and subsequently degraded by the proteasome. FGD1 and FGD3 share highly homologous Dbl homology (DH) and adjacent pleckstrin homology (PH) domains, both of which are responsible for GEF activity. However, their function and regulation are remarkably different. Here we demonstrate extracellular signal-responsive translocation of FGD1, but not FGD3. During the wound-healing process, translocation of FGD1 to the leading edge membrane occurs in cells facing to the wound. Furthermore, epidermal growth factor (EGF) stimulates the membrane translocation of FGD1, but not FGD3. As the most striking difference, FGD3 lacks the N-terminal proline-rich domain that is conserved in FGD1, indicating that proline-rich domain may play a crucial role in signal-responsive translocation of FGD1. Indeed, there is a faciogenital dysplasia patient who has a missense mutation in proline-rich domain of FGD1, by which the serine residue at position 205 is substituted with isoleucine. When expressed in cells, the mutant FGD1 with S(205)/I substitution fails to translocate to the membrane in response to the mitogenic stimuli. Thus we present a novel mechanism by which the activity of FGD1, a GEF for Cdc42, is temporally and spatially regulated in cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20045932     DOI: 10.1248/bpb.33.35

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  4 in total

1.  Ubiquitination: Added complexity in Ras and Rho family GTPase function.

Authors:  Michelle de la Vega; James F Burrows; James A Johnston
Journal:  Small GTPases       Date:  2011-07-01

2.  The Aarskog-Scott syndrome protein Fgd1 regulates podosome formation and extracellular matrix remodeling in transforming growth factor β-stimulated aortic endothelial cells.

Authors:  Thomas Daubon; Roberto Buccione; Elisabeth Génot
Journal:  Mol Cell Biol       Date:  2011-09-12       Impact factor: 4.272

3.  FGD3 binds with HSF4 to suppress p65 expression and inhibit pancreatic cancer progression.

Authors:  Feng Guo; Xiang Cheng; Boping Jing; Heshui Wu; Xin Jin
Journal:  Oncogene       Date:  2022-01-03       Impact factor: 9.867

4.  High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers.

Authors:  Scooter Willis; Yuliang Sun; Mark Abramovitz; Teng Fei; Brandon Young; Xiaoqian Lin; Min Ni; Justin Achua; Meredith M Regan; Kathryn P Gray; Robert Gray; Victoria Wang; Bradley Long; Roswitha Kammler; Joseph A Sparano; Casey Williams; Lori J Goldstein; Roberto Salgado; Sherene Loi; Giancarlo Pruneri; Giuseppe Viale; Myles Brown; Brian Leyland-Jones
Journal:  JCO Precis Oncol       Date:  2017-10-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.